LYON, France , July 31, 2017 -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that the Company submitted a 510(k) application for its Ablatherm Fusion device, enabling a more precise method for targeting of diagnosed areas within the prostate.

Webcast to be held Thursday, July 27 th , 2017 LYON, France , July 18, 2017 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that the Company plans to host an investor call with commentary from an American robotic surgeon and oncologist to

  New 510(k) With New Clinical Data to be Submitted for Focal One® Initial 510(k) to be submitted for Ablatherm Fusion® LYON, France , July 17, 2017 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that the Company has withdrawn the 510(k)

Billing code will take effect July 1st, 2017 LYON, France , May 22, 2017 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that the Centers for Medicare and Medicaid Services (CMS) have established a new billing code for HIFU ablation of

Total revenue of EUR 8.7 million ( USD 9.3 million ) for Q1 2017  +16.5% growth in HIFU treatment driven recurring revenues Strong cash position of EUR 20.3 million ( USD 21.7 million ) as of March 31, 2017 CMS Medicare C-code submission for HIFU reimbursement in the U.S.

EDAP Announces Ablatherm Fusion World Premiere during American Urology Association Annual Meeting in Boston, MA , May 12-16, 2017 EDAP to Showcase Ablatherm Fusion and Sonolith i-move at AUA Booth #130 LYON, France , May 11, 2017 -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic

LYON, France , May 2, 2017 - EDAP TMS SA (NASDAQ: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the first quarter ended March 31, 2017 , after the close of the financial markets on May 17, 2017 .

2016 Highlights Total revenue for 2016 reached double-digit growth, increasing to EUR 35.6 million ( USD 39.3 million ) Gross margin for 2016 expanded to 46.1% compared to 42.8% during the prior year period Strong cash position of EUR 22.0 million ( USD 23.2 million ) as of December 31, 2016 LYON,

Multicenter Retrospective Analysis of 418 Patients  LYON, France , March 22, 2017 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced the publication of a peer-reviewed article that analyzed Ablatherm Robotic HIFU for prostate tissue ablation in patients who

EDAP TMS SA to Report Fourth Quarter and Full Year 2016 Results on April 3, 2017 LYON, France , March 14, 2017 - EDAP TMS SA (NASDAQ: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the fourth quarter and year ended December 31,